谷歌浏览器插件
订阅小程序
在清言上使用

Tebentafusp in Combination with Durvalumab And/or Tremelimumab in Patients with Metastatic Cutaneous Melanoma: a Phase 1 Study

Journal for ImmunoTherapy of Cancer(2023)

引用 9|浏览16
关键词
Melanoma,Immune Checkpoint Inhibitors,T-Lymphocytes,Immunotherapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要